ADIL ADIAL PHARMACEUTICALS, INC.: institutional ownership and insider trading
17 funds reported holding $337K of ADIAL PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $258K, with 4 new positions and 2 funds selling out; over the last 12 months insiders bought $106K and sold $0 on the open market.
Famous investors holding ADIL
- Ken Griffin (Citadel Advisors): $75.6K, 0.0% of the portfolio
Largest institutional holders of ADIL
- JANE STREET GROUP, LLC — $82.2K
- CITADEL ADVISORS LLC — $75.6K
- UBS Group AG (UBS) — $49.0K
- StoneX Group Inc. (SNEX) — $35.7K
- GEODE CAPITAL MANAGEMENT, LLC — $31.7K
- China Universal Asset Management Co., Ltd. — $20.5K
- VANGUARD FIDUCIARY TRUST CO — $15.1K
- VANGUARD CAPITAL MANAGEMENT LLC — $14.9K
- Manchester Capital Management LLC — $7.71K
- Tower Research Capital LLC (TRC) — $3.63K
Recent ADIL insider trades
- Jul 16, 2026: Coastlands Capital LP bought 3,233 shares ($8.69K)
- Jul 10, 2026: Coastlands Capital LP bought 11,753 shares ($32.6K)
- Jun 29, 2026: Coastlands Capital LP bought 25,000 shares ($65.0K)
5%+ owners
- Coastlands Capital LP: 14.2% (Schedule 13G/A, filed Jul 1, 2026)